Related Experiment Video
Updated: Aug 12, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Cyclin D3 and p53 mediate sulforaphane-induced cell cycle delay and apoptosis in non-transformed human T lymphocytes
C Fimognari1, M Nüsse, F Berti
1Department of Pharmacology, University of Bologna, Via Irnerio 48, 40126 Bologna, Italy.
Abstract:
Despite experimental evidence that sulforaphane can exert chemopreventive effects, whether these effects are specific for neoplastic cells is not known. Following our previous demonstration that sulforaphane induces cell cycle arrest and apoptosis in human T lymphoblastoid Jurkat leukemia cells and increases p53 and bax protein expression, we tested sulforaphane on non-transformed phytohemagglutinin-stimulated human lymphocytes. Here, we demonstrate that sulforaphane arrested cell cycle progression in G, phase, through a decrease in the protein expression of cyclin D3. Moreover, sulforaphane induced apoptosis (and also necrosis), mediated by an increase in the expression of p53. These findings suggest that sulforaphane is a growth modulator for T cells. Our in vitro evidence that sulforaphane is active and even cytotoxic in normal as well as transformed lymphocytes raises important questions regarding its suitability for cancer chemoprevention.
Insights
Sulforaphane affects normal and cancerous T cells. This study shows sulforaphane impacts cell growth and survival in lymphocytes, raising questions about its use in cancer prevention.
Area of Science:
- Cell Biology
- Immunology
- Cancer Research
Background:
- Sulforaphane shows potential chemopreventive effects.
- Previous studies indicated sulforaphane induces cell cycle arrest and apoptosis in leukemia cells.
- The specificity of sulforaphane's effects on neoplastic versus normal cells remains unclear.
Purpose of the Study:
- To investigate the effects of sulforaphane on non-transformed human lymphocytes.
- To determine if sulforaphane's chemopreventive effects are specific to neoplastic cells.
Main Methods:
- Treatment of phytohemagglutinin-stimulated human lymphocytes with sulforaphane.
- Analysis of cell cycle progression using flow cytometry.
- Assessment of apoptosis and necrosis.
- Evaluation of protein expression, including cyclin D3 and p53.
Main Results:
- Sulforaphane induced cell cycle arrest at the G1 phase in normal human lymphocytes.
- A decrease in cyclin D3 protein expression was observed.
- Sulforaphane induced apoptosis and necrosis.
- Increased p53 protein expression was noted, mediating apoptosis.
Conclusions:
- Sulforaphane acts as a growth modulator for T cells, affecting both normal and transformed lymphocytes.
- The cytotoxic effects of sulforaphane on normal lymphocytes raise concerns about its suitability for cancer chemoprevention.
- Further research is needed to clarify the therapeutic window and safety profile of sulforaphane.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Positive Regulator Molecules
Inhibition of Cdk Activity
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle

